CLOV
NASDAQ · Health Care
Clover Health Investments Co
$4.46
-0.12 (-2.62%)
Financial Highlights (FY 2026)
Revenue
2.01B
Net Income
-89,357,430
Gross Margin
—
Profit Margin
-4.5%
Rev Growth
-17.9%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 38.2% | 38.2% |
| Operating Margin | -4.4% | -4.0% | 22.2% | 21.5% |
| Profit Margin | -4.5% | -4.2% | 17.0% | 15.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 2.01B | 2.45B | 264.97M | 231.04M |
| Gross Profit | — | — | 101.34M | 88.36M |
| Operating Income | -89,243,142 | -97,830,484 | 58.88M | 49.62M |
| Net Income | -89,357,430 | -97,955,769 | 45.14M | 34.96M |
| Gross Margin | — | — | 38.2% | 38.2% |
| Operating Margin | -4.4% | -4.0% | 22.2% | 21.5% |
| Profit Margin | -4.5% | -4.2% | 17.0% | 15.1% |
| Rev Growth | -17.9% | -17.9% | -4.7% | +0.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 233.18M | 276.16M |
| Total Equity | — | — | 675.38M | 742.87M |
| D/E Ratio | — | — | 0.35 | 0.37 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -87,592,741 | -101,355,790 | 76.57M | 66.07M |
| Free Cash Flow | — | — | 32.12M | 25.98M |